When it comes to hyaluronic acid (HA) dermal fillers, Juvederm and Restylane are two names that dominate the market — and for good reason. Both brands have decades of clinical data behind them, both are CE-certified, and both are widely trusted by aesthetic medicine practitioners around the world.
But choosing between them is not simply a matter of preference. The right choice depends on the treatment area, the desired outcome, the patient's tissue characteristics, and the specific rheological properties of each product. In this guide, we break down the key technical differences, clinical performance, and indication-by-indication recommendations to help you make an informed decision at the point of prescription.
Understanding the Core Technology
Before diving into indications, it's essential to understand what makes these two brands fundamentally different at a molecular level.
Juvederm: Vycross and Hylacross Technology
Juvederm, manufactured by Allergan Aesthetics (AbbVie), offers two cross-linking platforms within its portfolio.
The Vycross range — which includes Voluma, Vollure, and Volbella — combines low and high molecular weight hyaluronic acid to improve cross-linking efficiency. In contrast, the Hylacross range, which includes Juvederm Ultra and Ultra Plus, uses highly cross-linked, high molecular weight HA strands.
Vycross technology results in minimal swelling, enhanced smoothness, and longer duration. This makes it particularly suited for areas where tissue integration and longevity are priorities.
The Vycross collection — including Volift, Volbella, Voluma, and Volite — contains hyaluronic acid combined with 0.3% lidocaine, which significantly reduces pain during and after treatment.
Restylane: NASHA Technology
Restylane, produced by Galderma, is built on NASHA (Non-Animal Stabilized Hyaluronic Acid) technology. This produces a firmer, more particulate gel structure, compared to Juvederm's smoother, more homogeneous gel.
This firmness translates to stronger structural support, more precise projection, and better resistance to tissue movement — properties that are highly relevant in specific anatomical zones.
Key Rheological Differences
Understanding G-prime (G') — the elastic modulus, or stiffness of a gel — is fundamental to selecting the right filler.
A filler with a higher G-prime gives more projection. A lower G-prime filler feels softer and more integrated into the tissue.
In general terms:
- Juvederm products tend to have lower G-prime in their Vycross range, producing a smooth, spreadable gel ideal for soft tissue integration and natural-looking volume.
- Restylane products, with their NASHA structure, tend to offer higher cohesivity and better lift in areas requiring structural definition.
Juvederm's smoothness makes the injection process feel softer with slightly less swelling afterward. Restylane's structure provides better support in areas needing precise shaping.
Indication-by-Indication Comparison
1. Lips
This is one of the most contested areas between the two brands.
Juvéderm Ultra XC tends to be smoother and more spreadable, while Restylane is a touch more cohesive. For practitioners looking to add soft, hydrated volume with natural movement, Juvederm Volbella or Ultra XC are strong choices. For more structured lip definition — particularly cupid's bow sharpening or vermillion border work — Restylane Kysse's firmer consistency delivers greater precision.
Restylane Kysse is ideal for subtle, natural enhancement that moves beautifully when talking and smiling. Juvederm products like Ultra or Volbella are better suited when aiming for more noticeable volume or a sharply defined pout.
Clinical recommendation: Juvederm Volbella for hydration and subtle augmentation; Restylane Kysse for natural movement and definition; Juvederm Ultra XC for more pronounced volume.
2. Nasolabial Folds
Both brands perform extremely well in this area, and clinical data supports near-identical outcomes.
A comprehensive NIH study found a 90.4% responder rate for Juvederm Ultra Plus versus 89.6% for Restylane when treating severe nasolabial folds at six months.
Given these comparable results, product selection here can be guided by patient anatomy and injector preference. Juvederm Volift offers excellent longevity in this zone, while Restylane provides reliable structural correction.
Clinical recommendation: Either brand is appropriate. Juvederm Volift for longer-lasting correction; Restylane for precise structural fill.
3. Cheeks and Midface Volume
For volumisation and lifting of the midface, high G-prime products are required.
Juvederm Voluma offers high G' for deep support, making it suited for structural deep tissue placement and lift. It is one of the most widely used products for cheek augmentation globally.
Juvederm Voluma has been clinically proven to last up to 18 months.
Restylane Lyft (formerly Perlane) is the direct competitor in this space, offering comparable lift with a firmer gel structure that some practitioners prefer for sharp contour definition.
Clinical recommendation: Juvederm Voluma for smooth, long-lasting lift; Restylane Lyft for defined structural contouring.
4. Tear Troughs
The periorbital area is one of the most technically demanding zones, requiring low-viscosity, soft fillers with minimal risk of Tyndall effect.
Restylane is well-suited for tear troughs, effectively reducing dark circles and sunken areas. Its cohesive structure minimises migration risk, which is critical in this thin-skinned area.
Juvederm Volbella is also used in this indication by experienced practitioners, though its more spreadable nature requires careful placement to avoid the blue-grey discolouration associated with superficial injection.
Clinical recommendation: Restylane (or Restylane Eyelight where available) as the first-line option; Juvederm Volbella in expert hands for subtle correction.
5. Jawline and Chin
For structural definition of the lower face, high cohesivity and strong G-prime are essential.
Clinical studies have directly compared Restylane Shaype and Juvederm Volux for aesthetic chin augmentation, both showing strong outcomes in this indication.
Juvederm Volux offers high G' suited for deep support and structural work in the lower face. Restylane Shaype, with its firm NASHA-based gel, is equally capable of delivering precise definition along the mandibular border.
Clinical recommendation: Both Juvederm Volux and Restylane Shaype are top-tier choices; selection depends on injector familiarity and desired texture of result.
6. Skin Quality and Hydration
Both brands have dedicated skinbooster-type products for improving skin texture, elasticity, and hydration.
Juvederm Volite has been shown to provide significant improvements in skin quality for up to 6 months. Restylane's equivalent — Restylane Skinboosters (Vital and Vital Light) — targets similar indications and has strong clinical data supporting improvements in skin smoothness and elasticity.
Clinical recommendation: Both options are effective. Choice depends on the depth of treatment and desired skin improvement profile.
Longevity: Which Lasts Longer?
Treatment with Juvederm Vycross products lasts approximately 9 to 18 months depending on the indication and product: Volbella lasts up to 12 months, Volift up to 15 months, and Voluma up to 18 months.
Restylane demonstrates exceptional long-term satisfaction, with 86% of patients remaining satisfied with their chin, jawline, and lower face contouring results at 12 months post-treatment.
In general, Juvederm's Vycross products have a slight edge in longevity for volumising indications, while Restylane's longevity in structural areas remains highly competitive.
Safety Profile and Reversibility
Both brands are fully reversible with hyaluronidase, which is an important safety advantage of all HA-based fillers. Common side effects — redness, swelling, bruising, and tenderness at the injection site — are generally mild and resolve within a few days for both brands.
The main safety considerations differ slightly by rheology: Juvederm's smoother gel carries a marginally higher migration potential in thin-skinned areas, while Restylane's firmer structure can, in rare cases, feel more palpable if placed too superficially.
Summary Comparison Table
| Criteria | Juvederm | Restylane |
|---|---|---|
| Technology | Vycross / Hylacross | NASHA |
| Gel texture | Smooth, homogeneous | Firmer, particulate |
| Best for | Lips, cheeks, NLF | Tear troughs, jawline, contouring |
| Longevity (volumisers) | Up to 18 months | Up to 12–15 months |
| Lidocaine included | Yes (Vycross range) | Yes (most products) |
| Reversible | Yes (hyaluronidase) | Yes (hyaluronidase) |
Conclusion
Juvederm and Restylane are not competing products in the traditional sense — they are complementary tools in the aesthetic practitioner's arsenal. Juvederm's smooth, long-lasting Vycross gels excel in soft volumisation and midface lifting. Restylane's cohesive NASHA gels offer precision, structural support, and particular reliability in delicate or high-movement areas.
The best practitioners use both, selecting each product based on the anatomy of the zone, the clinical goal, and the individual patient's tissue characteristics. Rather than asking "which brand is better?", the right question is always: "which product, in which plane, for which indication?"
At Hyashop, both Juvederm and Restylane ranges are available for licensed medical professionals, with express delivery across Europe. Explore our full filler catalogue to source the right product for your next procedure.
Frequently Asked Questions (FAQ)
Can I use Juvederm and Restylane in the same session? Yes. Many experienced practitioners combine both brands in a single treatment session, selecting each product based on the zone being treated. For example, Juvederm Voluma for midface lifting and Restylane for tear trough correction is a common and clinically sound combination.
Is Juvederm or Restylane more painful to inject? Both brands include lidocaine in most of their formulations, which significantly reduces injection discomfort. Juvederm's smoother gel consistency is generally considered slightly more comfortable to inject, but the difference is minimal in clinical practice. The use of topical anaesthetic or a nerve block remains recommended for sensitive areas such as the lips regardless of brand.
Which filler is safer for the tear trough area? The tear trough is a high-risk zone for any HA filler due to the thin skin and proximity to the orbital rim. Restylane is generally preferred in this area due to its cohesive structure, which reduces the risk of migration and Tyndall effect. That said, outcomes are highly dependent on injection technique and practitioner experience — product choice alone does not guarantee safety.
How do I reverse Juvederm or Restylane if needed? Both are fully reversible with hyaluronidase. The enzyme dissolves the HA gel rapidly, typically within 24–48 hours. Every clinic performing filler injections should have hyaluronidase readily available as a safety measure, regardless of the brand used.
Does Juvederm last longer than Restylane? For volumising indications, Juvederm's Vycross products tend to show a slight longevity advantage — Voluma can last up to 18 months, compared to approximately 12–15 months for equivalent Restylane products. However, longevity is also influenced by the treatment area, injection depth, patient metabolism, and lifestyle factors, so results will vary between individuals.
Are these products available without a prescription in Europe? No. In most European countries, including France, the sale and administration of injectable HA fillers is strictly reserved for licensed medical professionals. In France specifically, Decree No. 2024-490 of 29 May 2024 reinforces this regulation. Always source your products through a verified, compliant supplier.
Which brand is better for lip filler in male patients? Male lip anatomy typically calls for more conservative augmentation with higher structural support and less projection than female treatments. Restylane Kysse or Juvederm Volift tend to work well in this context, as both offer definition without the soft fullness that can look incongruous in male patients. Practitioner assessment of individual anatomy remains paramount.
